This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2032

Conditions
Peripheral Arterial Disease
Trial Locations (1)

Unknown

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Chengdu University of Traditional Chinese Medicine

OTHER

collaborator

Xuanwu Hospital, Beijing

OTHER

collaborator

First People's Hospital of Hangzhou

OTHER

collaborator

Qingdao Hiser Medical Group

OTHER

collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

Liyuan Hospital of Tongji Medical College of Huazhong University of Science and Technology

UNKNOWN

collaborator

Huashan Hospital

OTHER

lead

Shanghai Zhongshan Hospital

OTHER